Skip to content

Increasing Viral Testing in the Emergency Department

Phase 2/3 Clinical Trial of the Effect of a Brief Intervention on Uptake of Rapid Testing for HIV and Hepatitis C Among Emergency Department Patients

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01419899
Acronym
InVITED
Enrollment
398
Registered
2011-08-18
Start date
2011-01-31
Completion date
2012-01-31
Last updated
2013-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug Use, Hepatitis C, HIV

Keywords

Brief intervention, Rapid testing

Brief summary

The purpose of this study is to determine if a brief intervention delivered to emergency department patients increases the uptake of rapid HIV and hepatitis C testing in comparison to no brief intervention.

Interventions

A 20-30 minute motivational based discussion

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Rhode Island Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

* Emergency department patient. * Does not know HIV or hepatitis C status. * Has an ASSIST V3 score that indicates recent illicit and/or prescription drug use. * Fluency in English or Spanish.

Exclusion criteria

* Critically ill or injured. * Homicidal and/or suicidal intention. * Age \< 18 years or \> 64 years. * Does not speak English or Spanish.

Design outcomes

Primary

MeasureTime frameDescription
The agreement of the participant to be tested for HIV and hepatitis CWithin four hours of being consented into the studyWe will measure the acceptance of free rapid testing for HIV and hepatitis C among the intervention and control groups

Secondary

MeasureTime frameDescription
Identifying risky sexual behaviors of study participantsWithin four hours of being consented into the studyIdentify factors that influence the relationship of BI and risk assessment vs. risk assessment alone on uptake of combined HIV and hepatitis C screening in the ED.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026